Stock 4105 TTY BIOPHARM COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company TTY Biopharm Company Limited

Equities

4105

TW0004105002

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
78 TWD -0.76% Intraday chart for TTY Biopharm Company Limited +1.17% -2.99%
14/03 TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
08/03 TTY Biopharm Company Limited Announces Change of CFO and Financial Officer CI

Business Summary

TTY Biopharm Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of pharmaceutical preparations. The Company mainly operates through six business segments including Cancer Drug segment, Healthcare segment, Anti-Infective Drug segment, Domestic Cardiovascular and Gastrointestinal Drug segment, Mainland Medical Drug segment and the Other segment. The main products include oncology medicines, anti-infective medicines and health care medicines. Oncology medicines are mainly anti-cancer and auxiliary drugs. Anti-infective medicines are mainly back-line antimicrobial agents and influenza vaccines. Medical and health care medicines are mainly gastrointestinal health care, bone health care, metabolic health care, infection treatment drugs. The Company distributes its products in domestic and overseas markets.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Cancer Drugs
44.1 %
2,970 58.7 % 2,430 44.1 % -18.17%
Anti-infective Drugs
18.4 %
- - 1,013 18.4 % -
Invest
14.8 %
- - 814 14.8 % -
Export Sales and OEM
14.5 %
- - 797 14.5 % -
Medical Insurance
7.0 %
179 3.5 % 386 7.0 % +115.77%
Other
1.2 %
283 5.6 % 65 1.2 % -76.87%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
87.9 %
4,596 90.8 % 4,841 87.9 % +5.33%
Other Countries
7.2 %
466 9.2 % 399 7.2 % -14.37%
America
4.8 %
-- 266 4.8 % -

Managers

Managers TitleAgeSince
Sara Hou CEO
 Chief Executive Officer - 18/22/18
Guo Jiang Zhang DFI
 Director of Finance/CFO - 31/15/31
Shu Fen Huang CMP
 Compliance Officer - 18/22/18
Nai Wei Liu ADM
 Chief Administrative Officer - 04/18/04
Shih-Chou Chen IRC
 Investor Relations Contact - -
Jung Liang Kao AUD
 Comptroller/Controller/Auditor - 26/21/26
Wen Po Huang PRN
 Corporate Officer/Principal - 04/21/04
Jen-Yang Chang HRO
 Human Resources Officer - 01/19/01
Shu-Wen Wang AUD
 Comptroller/Controller/Auditor - 13/15/13

Members of the board

Members of the board TitleAgeSince
Wen Hua Chang BRD
 Director/Board Member - 24/95/24
Hsiu Chi Chang BRD
 Director/Board Member - 24/16/24
Tzu Chiang Yang BRD
 Director/Board Member 68 24/16/24
Tien Fu Lin BRD
 Director/Board Member - 24/16/24
Chuan Lin CHM
 Chairman 72 22/18/22
Tui Tsai BRD
 Director/Board Member - 24/16/24
Ming-Ling Hsueh BRD
 Director/Board Member 68 24/16/24
Ying Ying Liao BRD
 Director/Board Member - 24/16/24
Carl Hsiao BRD
 Director/Board Member - 26/19/26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 248,650,000 200,715,959 ( 80.72 %) 0 80.72 %

Shareholders

NameEquities%Valuation
Quoniam Asset Management GmbH
0.3756 %
934,000 0.3756 % 2 M NT$
First Securities Investment Trust Co. Ltd.
0.1791 %
445,209 0.1791 % 1 M NT$
Mega International Investment Trust Co., Ltd.
0.1689 %
419,906 0.1689 % 1 M NT$
RAM Active Investments SA
0.0772 %
191,990 0.0772 % 469 124 NT$
DWS Far Eastern Investments Ltd.
0.0655 %
162,814 0.0655 % 397 833 NT$
Shin Kong Investment Trust Co., Ltd.
0.0345 %
85,680 0.0345 % 209 357 NT$
State Street Global Advisors Ltd.
0.0290 %
71,999 0.0290 % 175 928 NT$
Polen Capital HK Ltd.
0.0249 %
62,000 0.0249 % 151 496 NT$
Pension Reserves Investment Management Board
0.0193 %
47,976 0.0193 % 117 228 NT$
Dimensional Fund Advisors Ltd.
0.0186 %
46,196 0.0186 % 112 879 NT$

Company contact information

TTY Biopharm Co. Ltd.

No. 3-1, Park Street 3/F, Nangang District

115 03, Taipei

+

http://www.tty.com.tw
address TTY Biopharm Company Limited(4105)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for TTY Biopharm Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
78 TWD
Average target price
86.5 TWD
Spread / Average Target
+10.90%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TTY BIOPHARM COMPANY LIMITED Stock TTY Biopharm Company Limited
-2.99% 603M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4105 Stock
  4. Company TTY Biopharm Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW